Accra, Ghana – The Ghana Food and Drugs Authority (FDA) has issued a stern warning to the public to exercise extreme caution when purchasing palm oil, citing ongoing concerns about the adulteration of cancerous substances, notably the notorious ‘Sudan Four’ dye.
This warning comes amidst the FDA’s continued efforts to combat the presence of hazardous substances in palm oil products. Despite rigorous enforcement actions, the ‘Sudan Four’ dye has been detected in some palm oil products circulating on the market, posing a serious health risk to consumers.
Deputy Chief Executive Officer of the FDA, Mr. Roderick Daddey-Adjei, expressed deep concern over the persistence of ‘Sudan Four’ dye use by unscrupulous individuals. “We are still not happy about that small percentage that is there, which means that people who perpetrated the activity are still lurking in the dark,” he said.
Mr. Daddey-Adjei acknowledged progress in reducing the prevalence of adulterated palm oil but emphasized that even a small percentage of contamination remains unacceptable. The FDA has made arrests and handed suspects over to the police, signaling a crackdown on perpetrators.
The ‘Sudan Four’ dye, banned for use in food products due to its carcinogenic properties, has been a recurring issue in Ghana’s palm oil market. Consumers are advised to be vigilant and report any suspicious products to the FDA.
In a bid to ensure public safety, the FDA has intensified its market surveillance and testing of palm oil products. The authority urges consumers to prioritize their health and well-being by making informed choices when purchasing palm oil.
As the FDA continues its efforts to eradicate the presence of hazardous substances in palm oil, the public is urged to remain vigilant and report any suspicious activities to the authorities.
Ruth Abla ADJORLOLO
